Reditux 600 mg Injection
  1. Home
  2. Pharma Products
  3. Dr Reddy 's Laboratories Ltd
  4. Reditux 600 mg Injection

Reditux 600 mg Injection

Reditux 600 mg Injection contains rituximab 600 mg and is a monoclonal antibody medicine used for certain blood cancers and autoimmune conditions. It is supplied as a concentrate for intravenous infusion and must be administered by a healthcare professional. Rituximab targets CD20-positive B cells to help control abnormal immune or cancerous cell activity.

BUY NOW

Category

Reditux 600 mg Injection is used in conditions including non-Hodgkin lymphoma and chronic lymphocytic leukemia, with additional indications in selected autoimmune disorders. Rituximab is an anti-CD20 monoclonal antibody that binds to CD20 on B lymphocytes and promotes their depletion. The dosage and infusion schedule are determined by the treating specialist according to the indication and treatment protocol. Reditux 600 mg is marketed by Dr. Reddy’s Laboratories Ltd. and is supplied in a 60 mL vial.

Technical Specification

Specification Details
Active Ingredient Rituximab
Strength 600 mg
Dosage Form Concentrate for Solution for Infusion
Concentration 10 mg/mL
Route of Administration Intravenous Infusion
Pack Size 60 mL Vial

Product Also Known As

Reditux 600 mg Injection, Reditux 600 Injection, Reditux Rituximab 600 mg, Rituximab 600 mg Injection, Rituximab 600 mg/60 mL, Anti-CD20 Monoclonal Antibody Injection